可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology[J]. Eur Heart J, 2005, 26(8):804-847.
[2] Valgimigli M, van Mieghem CA, Ong AT, et al. Short- and long- term clinical cutcome after drug-eluting stent implitation for the percutaneous treatment of left main coronary artery disease:insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries(RESEACH and T-SEACH)[J]. Circulation, 2005, 111(11):1383-1389.
[3] Park SJ, Park SW, Hong MK, et al. Long term(three years) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function[J]. Am J Cardiol, 2003, 91(1):12-16.
[4] 无保护左主干病变的选择性支架术协作组. 无保护左主干病变的选择性支架术[J]. 中华心血管病杂志, 2000, 28(5):346-348.
[5] Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment wth drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience[J]. Circulation, 2006, 113(21):2542-2547.
[6] 陈万强,薛成相,张红宾,等.经桡动脉和股动脉途径行冠状动脉造影的对比研究[J]. 医师进修杂志, 2004, 27(4):26-27.
[7] Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study[J]. J Am Coll Cardiol, 1997, 29(6):1269-1275.